Výsledky vyhledávání

Akademický článek

Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study.

Autor: Alés-Martínez JE; Hospital Nuestra Sra. De Sonsoles, Ávila, Spain. Electronic address: jealesm@seom.org., Balmaña J; Hospital Universitari Vall D'Hebron, Barcelona, Spain., Sánchez-Rovira P; Hospital Universitario de Jaén, Jaén, Spain., Salvador Bofill FJ; Hospital Universitario Virgen del Rocío, Sevilla, Spain., García Sáenz JÁ; Hospital Clínico San Carlos, Madrid, Spain., Pimentel I; Hospital Universitari Vall D'Hebron, Barcelona, Spain., Morales S; Hospital Universitario Arnau de Vilanova de Lleida, Lleida, Spain., Fernández-Abad M; Hospital Universitario Ramón y Cajal, Madrid, Spain; Universidad de Alcalá de Henares, Madrid, Spain., Lahuerta Martínez A; Onkologikoa, Gipuzkoa, Spain., Ferrer N; Hospital Universitari Son Espases, Illes Balears, Spain., Zamora P; Hospital Universitario de La Paz, Madrid, Spain., Bermejo B; Hospital Clínico Universitario de Valencia, Valencia, Spain., Díaz-Redondo T; Unidad de Gestión Clínica Intercentros de Oncología, Hospitales Universitarios Regional y Virgen de la Victoria de Málaga, Málaga, Spain., López-Ceballos MH; Hospital San Pedro de Alcántara, Cáceres, Spain., Galán M; Hospital Son Llàtzer, Palma de Mallorca, Spain., Pérez-Escuredo J; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City (New Jersey, USA), Sao Paulo, Brazil., Calabuig L; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City (New Jersey, USA), Sao Paulo, Brazil., Sampayo M; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City (New Jersey, USA), Sao Paulo, Brazil., Pérez-Garcia JM; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City (New Jersey, USA), Sao Paulo, Brazil; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain., Cortés J; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City (New Jersey, USA), Sao Paulo, Brazil; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain; IOB Madrid, Hospital Beata María Ana, Madrid, Spain., Llombart-Cussac A; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City (New Jersey, USA), Sao Paulo, Brazil; Hospital Arnau de Vilanova, FISABIO, Valencia, Spain; Universidad Católica de Valencia, Valencia, Spain.

Publikováno v: Breast (Edinburgh, Scotland) [Breast] 2024 Oct; Vol. 77, pp. 103780. Date of Electronic Publication: 2024 Aug 02.

Zobrazit plný text záznamu

Akademický článek

Development of a 5-Step Electronic Medical Record-Based Algorithm to Identify Patients with Opioid Use Disorder in Pregnancy.

Autor: Fryer K; University of South Florida, Tampa, Florida., Reid CN; University of South Florida, Tampa, Florida., Chaphalkar C; University of South Florida, Tampa, Florida., Marshall J; University of South Florida, Tampa, Florida., Szalacha L; University of South Florida, Tampa, Florida., Johnson K; University of South Florida, Tampa, Florida., Wright T; University of South Florida, Tampa, Florida., Read C; University of South Florida, Tampa, Florida., Khan A; University of South Florida, Tampa, Florida., Wilson A; University of South Florida, Tampa, Florida., Ratani M; University of South Florida, Tampa, Florida., Cox K; University of South Florida, Tampa, Florida., Tavolieri A; University of South Florida, Tampa, Florida., Sampayo M; University of South Florida, Tampa, Florida., Su R; University of South Florida, Tampa, Florida., Campbell K; University of South Florida, Tampa, Florida., Salemi JL; University of South Florida, Tampa, Florida.

Publikováno v: Journal of registry management [J Registry Manag] 2024 Summer; Vol. 51 (2), pp. 69-74.

Zobrazit plný text záznamu

The impact of public health crises on Lisbon public space policies: From the 19th century to the present days

Autor: Narciso, J., Sampayo, M.

Publikováno v: PROCEEDINGS OF THE 10TH WORKSHOP ON METALLIZATION AND INTERCONNECTION FOR CRYSTALLINE SILICON SOLAR CELLS.

Cities have been affected, throughout History, by earthquakes, big fires, epidemics, and pandemics that sparked moments of reflection and change in the city form and public space quantity and quality. For example, this happened after the Great Fire o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a2081cafcc85cff1977540155f15e50
https://doi.org/10.1063/5.0108435

Zobrazit plný text záznamu

The typo-morphological facade of the catholic churches of S. Miguel, Azores

Autor: Vieira, M. A., Sampayo, M., Cunha, J. A. da.

This paper intends to present the research results that comprised a comparative facade analysis of 41 parish and non-parish Catholic churches on the island of S. Miguel, Azores, built during the 18th and 19th centuries. The research highlights the ex

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1199::bb73d3d3095abaa2ad69a2b0349438bb
https://hdl.handle.net/10071/27689

Zobrazit plný text záznamu

A phase II proof-of-concept study of palbociclib (P) rechallenge in patients (pts) with hormone receptor (HR)[+]/HER2[-] metastatic breast cancer (MBC) and clinical benefit to prior P-based treatment (BIOPER)

Publikováno v: CANCER RESEARCH
r-FISABIO. Repositorio Institucional de Producción Científica
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::bcbe30c27c4e0b88a7a1b12f0168f48b
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=12708

Zobrazit plný text záznamu

First-line osimertinib in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer and with a coexisting low allelic fraction of Thr790Met

Autor: Majem, M, Sullivan, I, Viteri, S, Lopez-Vivanco, G, Cobo, M, Sanchez, JM, Garcia-Gonzalez, J, Garde, J, Sampayo, M, Martrat, G, Malfettone, A, Karachaliou, N, Molina-Vila, MA, Rosell, R

Publikováno v: EUROPEAN JOURNAL OF CANCER
r-FISABIO. Repositorio Institucional de Producción Científica
instname
European Journal of Cancer
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau

Aim of the study: The AZENT (NCT02841579) study aimed to assess the efficacy and safety of first-line osimertinib in patients with epidermal growth factor receptor(EGFR) mutation-positive advanced non-small-cell lung cancer (NSCLC) and with a coexist

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0d5cc9b707e8f28dd4356b087e9b25ac
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=12661

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání